Skip to main content
. 2021 Dec 4;12(2):11784–11796. doi: 10.1080/21655979.2021.1996508

Figure 2.

Figure 2.

Synergistic effects of BBR and Rb1 on inflammation and the proliferation of TNF-α-treated adipocytes. (a) Cell viability was determined via MTT assay (**, p < 0.01, compared to Control; ##, p < 0.01, compared to TNF-α; &, p < 0.05, compared to BBR or Rb1). (b) IL-6, IL-1β, and TNF-α levels were measured by performing ELISA (**, p < 0.01, compared to Control; ##, p < 0.01, compared to TNF-α; &, p < 0.05, compared to BBR or Rb1; &&, p < 0.01, compared to BBR or Rb1). (c) The expression levels of Bcl-2 and cleaved caspase-3 were determined in western blot assays (**, p < 0.01, compared to Control; #, p < 0.05, compared to TNF-α; ##, p < 0.01, compared to TNF-α; &, p < 0.05, compared to BBR or Rb1; &&, p < 0.01, compared to BBR or Rb1)